STVNNYSESurgical & Medical Instruments & Apparatus

Stevanato Group S.p.A.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 4, 2026

$19.02+0.12 (+0.63%)

Close on Oct 19, 2026

Fundamental chart

Pick a measure to chart its full history

€1.19BFY2025, +14.1% a year since FY2019

Parsed from the XBRL in Stevanato Group S.p.A.'s annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is STVN.

Revenue growth7.4% · median 10.2%

Gross margin29.0% · median 52.5%

Operating margin16.8% · median 12.8%

Net margin11.8% · median 8.6%

Advertisement
300 × 250